In fact, we found that ANGPTL2 mRNA levels were positively correlated with those of HLA‐A, HLA‐B, and HLA‐C in melanoma patients (Fig. S5B), suggesting that in this cancer context ANGPTL2 signaling does not regulate MHC‐I expression. Here, HLA-B is linked to melanoma.